CellR4 - Page 7 of 20 - Cellular repair, replacement, regeneration, reprogramming and differentiation

CellR4 2017; 5 (2): e2298

Purified Human Pancreatic Islets with Lisofylline, Certificate of Analysis (Product Code PHPI-L-01) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2296

Purified Human Pancreatic Islets with Lisofylline, Interim Certificate of Analysis (Product Code PHPI-L-01) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2294

PHPI, MPBR, Part 2B (Product Code PHPI-L-01, Islets with Lisofylline) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2292

PHPI, MPBR, Part 2B (Product Code PHPI-L-01 OR PHPI-E-01, Islets with Lisofylline or Exenatide) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2290

PHPI, MPBR, Part 2A (Product Code PHPI-A-01, Islets Alone) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2288

PHPI, MPBR, Part 2A (Product Code PHPI-A-01, Islets Alone) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2286

Purified Human Pancreatic Islets Master Production Batch Record, Part 1 University of Illinois, Chicago & University of Miami (Product Codes PHPI-A-01 & PHPI-L-01) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2284

Purified Human Pancreatic Islets Master Production Batch Record, Part 1 University of Illinois, Chicago & University of Miami (Product Codes PHPI-A-01, PHPI-E-01, PHPI-L-01) – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2280

Raw Material Specification, Exenatide, 250 μg/mL – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2278

Raw Material Specification, Lisofylline, 60 mg/mL – Standard Operating Procedure of the NIH Clinical Islet Transplantation Consortium

CellR4 2017; 5 (2): e2251

Commentary – A hard lesson about transplanting islets into prevascularized devices

Colton C. K.

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
ckcolton@mit.edu

, Weir G.

Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA

CellR4 2017; 5 (1): e2239

Superficial enhanced fluid fat injection (SEFFI and MicroSEFFI) in facial rejuvenation

Gennai A.

Plastic, Reconstructive, and Aesthetic Surgery, University of Camerino, Camerino, Italy
agennai@mac.com

, Bernardini F. P.

Private Oculoplastic Surgery, Genoa, Italy

CellR4 2017; 5 (1): e2236

“Teaching Kitchens”: from nutrition and lifestyle coaching to culinary medicine

Nicosia R.

Diabetes Research Institute, University of Miami, Miami, FL, USA

, Lanzoni G.

Diabetes Research Institute, University of Miami, Miami, FL, USA
glanzoni@med.miami.edu

, Eisenberg D. M.

Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA

CellR4 2016; 4 (6): e2214

Vitamin D status in children and adolescents with type 2 diabetes in a sun-rich environment

Gomez-Meade C. A.

Division of Pediatric Endocrinology, University of Miami Miller School of Medicine, Miami, FL, USA

, Lopez-Mitnik G.

Division of Pediatric Clinical Research, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA

, Messiah S. E.

Division of Pediatric Clinical Research, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA

, Garcia-Contreras M.

Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA

, Sanchez J.

Division of Pediatric Endocrinology, University of Miami Miller School of Medicine, Miami, FL, USA
jsanchez@med.miami.edu

CellR4 2016; 4 (6): e2212

In vitro multilineage potential and immunomodulatory properties of adipose derived stromal/stem cells obtained from nanofat lipoaspirates

Rossi M.

Department of Experimental, Diagnostic and Specialty Medicine, Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy

, Alviano F.

Department of Experimental, Diagnostic and Specialty Medicine, Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy
francesco.alviano@unibo.it

, Ricci F.

Service of Immunohematology and Transfusion Medicine, St. Orsola University Hospital, Bologna, Italy

, Vignoli F.

Dott. Maurizio Vignoli” Private Institute of Plastic Surgery, Bologna, Italy

, Marchionni C.

Department of Experimental, Diagnostic and Specialty Medicine, Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy

, Valente S.

Department of Experimental, Diagnostic and Specialty Medicine, Clinical Pathology, University of Bologna, Bologna, Italy

, Zannini C.

Department of Experimental, Diagnostic and Specialty Medicine, Unit of Nephrology, Dialysis and Renal Transplant, St. Orsola University Hospital, Bologna, Italy

, Tazzari P. L.

Service of Immunohematology and Transfusion Medicine, St. Orsola University Hospital, Bologna, Italy

, Vignoli M.

Dott. Maurizio Vignoli” Private Institute of Plastic Surgery, Bologna, Italy,

, Bartoletti E.

Service of Aesthetic Medicine, San Giovanni Calibita Fatebenefratelli General Hospital, Isola Tiberina, Rome, Italy

, Bonsi L.

Department of Experimental, Diagnostic and Specialty Medicine, Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy

Newer
1
2
3
4
5
6
7
8
9
10
11
12
…
20
Older